Zenith Drugs Ltd
ZENITHDRUGZenith Drugs Ltd
ZENITHDRUG
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 2.23 | 0.62% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.49 | 6.67 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Zenith Drugs is an India-based pharmaceutical manufacturing and trading company.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2022 | FY 2023 | FY 2024 | TTM | ||||
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 92.67 | 115.76 | 133.90 | — | ||||
Raw Materials | 49.14 | 45.52 | 36.41 | — | ||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | |||||
| Employee Cost | 2.84 | 4.09 | 5.34 | |||||
| Selling & Administrative Expenses | 6.53 | 15.59 | 15.63 | |||||
| Operating & Other expenses | 26.19 | 40.27 | 58.77 | |||||
EBITDA | 7.97 | 10.29 | 17.75 | — | ||||
| Depreciation/Amortization | 1.33 | 1.31 | 1.30 | — | ||||
| PBIT | 6.64 | 8.98 | 16.45 | — | ||||
| Interest & Other Items | 2.24 | 2.33 | 3.00 | — | ||||
| PBT | 4.40 | 6.65 | 13.45 | — | ||||
| Taxes & Other Items | 1.27 | 1.78 | 3.84 | — | ||||
| Net Income | 3.13 | 4.87 | 9.61 | — | ||||
| EPS | 78.25 | 121.75 | 10.95 | — | ||||
| DPS | 0.00 | 0.00 | 0.50 | — | ||||
| Payout ratio | 0.00 | 0.00 | 0.05 | — |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Zenith Drugs Ltd | 14.49 | 2.23 | 0.62% |
| Sun Pharmaceutical Industries Ltd | 46.13 | 6.58 | 0.73% |
| Cipla Ltd | 29.21 | 4.49 | 0.87% |
| Mankind Pharma Ltd | 62.91 | 12.57 | — |
Price Comparison
Compare ZENITHDRUG with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Sep 2023
Feb 2024
Mar 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 17, 2024
Dividend/Share
₹0.50
Ex DateEx Date
Sep 17, 2024
Zenith Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant